January 06, 2025 04:01 am (IST)
Follow us:
facebook-white sharing button
twitter-white sharing button
instagram-white sharing button
youtube-white sharing button
Bharatiya Janata Party releases first list of candidates for Delhi Assembly polls, fields Parvesh Sahib Singh Verma against Kejriwal | Firecracker unit explosion in Tamil Nadu's Virudhunagar kills 6 | Body of independent journalist, who went missing on Jan 1, found in a septic tank in Chhattisgarh | Delhi: 14-year-old student stabbed to death outside school after brawl with classmate | Rohit Sharma confirms he is not retiring amid speculations after skipping Sydney Test | India objects to China's 'new counties' announcement, says parts of these come under Ladakh | No cause for alarm over HMPV virus spread in China: Indian Health Agency | PM Modi gives a call for change in Delhi launching fierce attack on Arvind Kejriwal's AAP | Quran open to passage glorifying violence, bomb-making materials tracked in New Orleans attacker Shamshud-Din Jabbar's home | Jasprit Bumrah leads India in series decider after Rohit Sharma opts to rest in Sydney Test amid poor show with willow

GlaxoSmithKline Consumer Healthcare records 7.5 % growth for Q1 FY 2016

| | Aug 06, 2015, at 03:41 am
New Delhi, Aug 5 (IBNS): GlaxoSmithKline Consumer Healthcare Limited on Wednesday declared its financial results for the first quarter ended June 30, 2015.
Net sales at Rs 990 crores recorded a growth of 7.5% over 2014 with PAT at Rs. 155 crores growing by 19.1% for the same period and PBT at Rs 238 crores growing by 20.1%.

Commenting on the results,  Manoj Kumar, Managing Director, GlaxoSmithKline Consumer Healthcare Limited said, “The first quarter has begun on a positive note – Horlicks and Boost are among the top three HFD in the country. We continue to stay ahead of the category, increasing our market share and volumes. Our growth is a reflection of distribution expansion, enhanced marketing campaigns as we continue to bring nutrition to suit each lifestyle and support all lifecycle.”

"Our efforts for the future will be to continue to service the unmet needs of the consumers through health enhancing products backed by high science. We will continue to focus on our distribution process so that our products reach more people at price points that are competitive and thereby bringing health to everyone,” Kumar said.
 

 

Support Our Journalism

We cannot do without you.. your contribution supports unbiased journalism

IBNS is not driven by any ism- not wokeism, not racism, not skewed secularism, not hyper right-wing or left liberal ideals, nor by any hardline religious beliefs or hyper nationalism. We want to serve you good old objective news, as they are. We do not judge or preach. We let people decide for themselves. We only try to present factual and well-sourced news.

Support objective journalism for a small contribution.